Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement

SM Grundy, JI Cleeman, SR Daniels, KA Donato… - Circulation, 2005 - Am Heart Assoc
strongly with insulin resistance. Excess upper body fat can accumulate either
intraperitoneally (visceral fat) or subcutaneously. Many investigators claim that excess …

Cholesterol and breast cancer risk: a systematic review and meta-analysis of prospective studies

M Touvier, P Fassier, M His, T Norat… - British Journal of …, 2015 - cambridge.org
The objective of the present study was to conduct the first systematic review and meta-
analysis of prospective studies investigating the associations between total cholesterol (TC) …

Brown adipose tissue activity controls triglyceride clearance

A Bartelt, OT Bruns, R Reimer, H Hohenberg, H Ittrich… - Nature medicine, 2011 - nature.com
Brown adipose tissue (BAT) burns fatty acids for heat production to defend the body against
cold, and has recently been shown to be present in humans,,. Triglyceride-rich lipoproteins …

Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1

C Cavelier, I Lorenzi, L Rohrer… - Biochimica Et Biophysica …, 2006 - Elsevier
Plasma levels of high-density lipoproteins (HDL) and apolipoprotein AI (apoA-I) are
inversely correlated with the risk of cardiovascular disease. One major atheroprotective …

Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer

J Ahn, U Lim, SJ Weinstein, A Schatzkin… - … , biomarkers & prevention, 2009 - AACR
Background: Circulating total cholesterol has been inversely associated with cancer risk;
however, the role of reverse causation and the associations for high-density lipoprotein …

Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease

KJE Sattler, Ş Elbasan, P Keul, M Elter-Schulz… - Basic research in …, 2010 - Springer
High-density lipoproteins (HDL) are the major plasma carriers for sphingosine 1-phosphate
(S1P) in healthy individuals, but their S1P content is unknown for patients with coronary …

Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy

H Jafri, AA Alsheikh-Ali, RH Karas - Journal of the American College of …, 2010 - jacc.org
Objectives: We sought to examine the relationship between high-density lipoprotein
cholesterol (HDL-C) levels and the risk of the development of cancer in large randomized …

Visceral obesity and the heart

P Mathieu, P Pibarot, É Larose, P Poirier… - The international journal …, 2008 - Elsevier
Obesity and particularly its deleterious form, visceral adiposity, has reached a high
prevalence in the industrialized world owing to the lack of exercise and the widely available …

Lipoproteins in inflammation and sepsis. I. Basic science

O Murch, M Collin, CJ Hinds, C Thiemermann - Intensive care medicine, 2007 - Springer
Background High-density lipoproteins (HDL) have been shown to bind and neutralize
lipopolysaccharide (LPS) and are regarded as possible therapeutic agents for sepsis and …

Prognostic role of serum total cholesterol and high-density lipoprotein cholesterol in cancer survivors: A systematic review and meta-analysis

P Zhou, B Li, B Liu, T Chen, J Xiao - Clinica chimica acta, 2018 - Elsevier
Background The alterations of lipid profile in cancer has been reported to be associated with
cancer development. However, the prognostic value of serum lipid markers level in cancer is …